TOULOUSE, France--(BUSINESS WIRE)--Vexim, a medtech company specializing in the minimally invasive, anatomical treatment of vertebral compression fractures, has announced the appointment of Vincent Gardès as Chief Executive Officer. Vincent Gardès has over 15 years of international experience in marketing, sales and general management in the medtech industry. His appointment comes at a time when Vexim is accelerating the international deployment of the Spinejack®.